Differential expression of LRRC59 in pan‐cancers was analyzed based on TIMER database, and the result showed that LRRC59 expression was elevated in bladder, breast, colon cancers, and cholangiocarcinoma (Figure 1A). Here, LRRC59 is linked to cholangiocarcinoma.